These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12719458)

  • 1. Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
    Bukholm IR; Bukholm G; Holm R; Nesland JM
    J Clin Pathol; 2003 May; 56(5):368-73. PubMed ID: 12719458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
    Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A
    J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
    Kühling H; Alm P; Olsson H; Fernö M; Baldetorp B; Parwaresch R; Rudolph P
    J Pathol; 2003 Apr; 199(4):424-31. PubMed ID: 12635132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
    Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
    Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
    Niméus-Malmström E; Koliadi A; Ahlin C; Holmqvist M; Holmberg L; Amini RM; Jirström K; Wärnberg F; Blomqvist C; Fernö M; Fjällskog ML
    Int J Cancer; 2010 Aug; 127(4):961-7. PubMed ID: 19957331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC; Chan JK; Lee KC; Hsiao WL
    J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
    World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues.
    Todorov IT; Werness BA; Wang HQ; Buddharaju LN; Todorova PD; Slocum HK; Brooks JS; Huberman JA
    Lab Invest; 1998 Jan; 78(1):73-8. PubMed ID: 9461123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
    Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
    Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
    Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
    Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.